Spectacle correction attains 20/25 in children with bilateral refractive amblyopia

Article

Treatment of bilateral refractive amblyopia, primarily with only spectacle correction, improves binocular visual acuity in children aged 3 to less than 10 years, with most achieving 20/25 acuity or better within 1 year, reported David Wallace, MD, for the Pediatric Eye Disease Investigator Group. Dr. Wallace is from the Department of Ophthalmology, Duke University, Durham, NC.

Treatment of bilateral refractive amblyopia, primarily with only spectacle correction, improves binocular visual acuity in children aged 3 to less than 10 years, with most achieving 20/25 acuity or better within 1 year, reported David Wallace, MD, for the Pediatric Eye Disease Investigator Group. Dr. Wallace is from the Department of Ophthalmology, Duke University, Durham, NC.

"Bilateral refractive amblyopia can develop in children with large amounts of uncorrected hypermetropia and/or astigmatism and is generally treated with the appropriate correction," Dr. Wallace said. "The prevalence of bilateral refractive amblyopia is about 0.5%."

A total of 113 children were enrolled prospectively in the study that was conducted at 27 sites. The study sought to determine both the amount and the time course of the improvement in binocular visual acuity in the patient group. Inclusion criteria included untreated bilateral refractive amblyopia that was defined as 20/40 to 20/400 best-corrected binocular visual acuity in each eye and binocularly and 4 D or greater of hypermetropia, and/or 2 D or more of astigmatism in each eye.

The children received optimal spectacle correction and were followed for 1 year. They were evaluated at baseline and at 5, 13, 26, and 52 weeks. Treatment with atropine or patching was done at the discretion of the treating physician, Dr. Wallace said.

During the follow-up period, 96 patients (85%) were treated with spectacle correction alone and 17 patients (15%) were treated with patching or atropine and spectacle correction. A total of 109 patients completed the 52-week visit.

Dr. Wallace reported that spectacle compliance was excellent at each visit in 68% of children, with excellent defined as spectacles that were worn 75% to 100% of waking hours.

"At 1 year the mean binocular best-corrected visual acuity improved from a mean baseline logMAR visual acuity of 0.5 to 0.11 for a mean improvement of 3.9 lines (95% confidence interval, 3.5 to 4.2)," he reported.

Investigators found that the worse the baseline binocular visual acuity (20/100 to 20/320), the greater was the improvement in the visual acuity, i.e., 6.3 lines (confidence interval, 4.9 to 7.3). Those patients with better baseline acuity improved less.

"Treatment of bilateral refractive amblyopia with spectacle correction substantially improves the binocular visual acuity in children aged 3 to less than 10 years," Dr. Wallace concluded. "Most of the children in the study cohort improved to 20/25 or better after 1 year. These improvements in vision and stereopsis were generally achieved with spectacles alone."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.